[1] |
廖二元. 内分泌代谢病学[M]. 3版. 北京: 人民卫生出版社, 2002:579-581.
|
[2] |
Albright F, Bumett CH, Smmithp H, et al. Pseudo-hypopara-thyroidism: An exsample of Seabright-Bantam syndrome[J]. Endocrinology, 1942, 30:922-923.
|
[3] |
Nakamura Y, Matsumoto T, Tamakoshi A, et al. Prevalence of idiopathic hypoparathyroidism and pseudohypoparathyroidism in Japan[J]. J Epidemiol, 2000, 10(1):29-33.
pmid: 10695258
|
[4] |
Underbjerg L, Sikjaer T, Mosekilde L, et al. Pseudohypoparathyroidism-epidemiology, mortality and risk of complications[J]. Clin Endocrinol (Oxf), 2016, 84(6): 904-911.
doi: 10.1111/cen.12948
URL
|
[5] |
Lee YS, Kim HK, Kim HR, et al. Identification of a novel mutation in a patient with pseudohypoparathyroidism type Ia[J]. Korean J Pediatr, 2014, 57(5):240-244.
doi: 10.3345/kjp.2014.57.5.240
pmid: 25045367
|
[6] |
Long DN, Meguire S, Levine MA, et al. Body mass index differences in pseudohypoparathyroidism type Ia versus pseudohypoparathyroidism may implicate paternal imprinting of Galpha(S) in the development of human obesity[J]. J Clin Endocrinol Metab, 2007, 92(3):1072-1079.
|
[7] |
谷伟军, 舒画. 甲状旁腺激素不敏感综合征研究进展[J]. 药物与临床, 2014, 11(23):35-40.
|
[8] |
lli FM, de Sanctis L, Ceoloni B, et al. Pseudohypoparathyroidism type Ia and pseudo-pseudohypoparathyroidism: The growing spectrum of GNAS inactivating mutations[J]. Hum Mutat, 2013, 34(3):411-416.
doi: 10.1002/humu.22265
pmid: 23281139
|
[9] |
吕秋, 秦炯. 假性甲状旁腺功能减退症的诊断与治疗研究进展[J]. 中华实用儿科杂志, 2015, 30(8):1278-1280.
|
[10] |
吕娟, 张立琴, 杜玮, 等. 以先天甲状腺功能减退为首发症状的假性甲状旁腺功能减退症临床家系分析[J]. 临床儿科杂志, 2018, 12(36):894-897.
|
[11] |
唐艳, 黎涛, 王覃, 等. 不同类型甲状旁腺功能减退症的临床特点[J]. 中华骨质疏松和骨矿盐疾病杂志, 2017, 9(10):462-468.
|
[12] |
Mantovani G, Ferrante E, Giavoli C, et al. Recombinant human GH replacement therapy in children with pseudohypoparathyroidism type Ia: First study on the effect on growth[J]. J Clin Endocrinol Metab, 2010, 95(11): 5011-5017.
doi: 10.1210/jc.2010-1649
pmid: 20719837
|